Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
Pfizer
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01072890
First received: February 16, 2010
Last updated: March 26, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
No publications provided by University of California, Davis

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):